{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-001050","form_type":"8-K","ticker":"SBC","cik":"0001930313","company_name":"SBC Medical Group Holdings Inc","filed_at":"2025-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.593008+00:00","generated_at":"2026-05-24T03:24:06.157327+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SBC Medical Q4 revenue down 29% to $44M; FY 2024 net income up 18% to $47M","bullets":["Q4 2024 revenue $44M (down 29% YoY); net income $7M (down 54% YoY); EPS $0.06 (down 58%).","Full-year 2024 revenue $205M (up 6% YoY); net income $47M (up 18% YoY); EPS $0.48 (up 14%).","Q4 EBITDA $21M (down 22% YoY) with margin 47%; full-year EBITDA $89M (up 8% YoY) with margin 43%.","Partner clinics grew by 43 to 251 as of Dec 31, 2024, expanding the clinic network.","Income from operations fell 80% in Q4 to $5M but was nearly flat for the full year at $70M."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-001050","json":"https://secwatch.observer/filing/0001641172-25-001050.json","markdown":"https://secwatch.observer/filing/0001641172-25-001050.md","text":"https://secwatch.observer/filing/0001641172-25-001050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1930313/000164117225001050/0001641172-25-001050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1930313/000164117225001050/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:24:06.157327+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}